According to the American Cancer Society, it is expected that more than 7,200 women in New Jersey will be diagnosed with breast cancer this year and nearly 1,300 will die from the disease. The Jattrude Fogarty Trust is committed to improving these statistics. Since 1996, the Trust has funded $620,000 in breast cancer research at Rutgers Cancer Institute of New Jersey. “It’s been very rewarding to know that these funds have helped the Cancer Institute maintain a pipeline of innovative research and leveraged the attainment of large scale grants,” notes Alexis Tucci, Jattrude Fogarty Trustee. Shridar Ganesan, MD, PhD, associate director for translational science at the Cancer Institute, emphasized the importance of philanthropy. “Private support is critical to sustaining a strong research program. I received a research award funded by the Jattrude Fogarty Trust and it allowed me to gather the preliminary data needed for me to obtain a National Cancer Institute research grant,” he said.